...
首页> 外文期刊>Journal of chemical crystallography >Central Nervous System Drugs: Low Temperature X-ray Structures of (I) the Base 5-(2,3-Dichlorophenyl)-2,4-diamino-6-fluoromethyl-pyrimidine (4030W92) and (II) 5-(2,6-Dichlorophenyl)-1-H-2,4-diamino-6-methyl-pyrimidine methanesulphonic acid salt (227C89)
【24h】

Central Nervous System Drugs: Low Temperature X-ray Structures of (I) the Base 5-(2,3-Dichlorophenyl)-2,4-diamino-6-fluoromethyl-pyrimidine (4030W92) and (II) 5-(2,6-Dichlorophenyl)-1-H-2,4-diamino-6-methyl-pyrimidine methanesulphonic acid salt (227C89)

机译:中枢神经系统药物:(I)5-(2,3-二氯苯基)-2,4-二氨基-6-氟甲基-嘧啶(4030W92)和(II)5-(2, 6-二氯苯基)-1-H-2,4-二氨基-6-甲基-嘧啶甲磺酸盐(227C89)

获取原文
获取原文并翻译 | 示例
           

摘要

The X-ray crystal structures of (I), the base 4030W92, 5-(2,3-dichlorophenyl)-2,4-diamino-6-fluoromethyl-pyrimidine, C11H9Cl2FN4, and (II) 227C89, the methanesulphonic acid salt of 5-(2,6-dichlorophenyl)-1-H-2,4-diamino-6-methyl-pyrimidine, C11H11Cl2N4 center dot CH3O3S, have been carried out at low temperature. A detailed comparison of the two structures is given. Structure (I) is non-centrosymmetric, crystallizing in space group P2(1) with unit cell a = 10.821(3), b = 8.290(3), c = 13.819(4) angstrom, beta = 105.980(6)degrees, V = 1191.8(6) angstrom(3), Z = 4 (two molecules per asymmetric unit) and density (calculated) = 1.600 mg/m(3). Structure (II) crystallizes in the triclinic space group P (1) over bar with unit cell a = 7.686(2), b = 8.233(2), c = 12.234(2) angstrom, alpha = 78.379(4), beta = 87.195(4), gamma = 86.811(4)degrees, V = 756.6(2) angstrom(3), Z = 2, density (calculated) = 1.603 mg/m(3). Final R indices [I > 2sigma(I)] are R1 = 0.0572, wR2 = 0.1003 for (I) and R1 = 0.0558, wR2 = 0.0982 for (II). R indices (all data) are R1 = 0.0983, wR2 = 0.1116 for (I) and R1 = 0.1009, wR2 = 0.1117 for (II). 5- Phenyl-2,4 diaminopyrimidine and 6-phenyl-1,2,4 triazine derivatives, which include lamotrigine (3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine), have been investigated for some time for their effects on the central nervous system. The three dimensional structures reported here form part of a newly developed data base for the detailed investigation of members of this structural series and their biological activities.
机译:(I)的X射线晶体结构,碱4030W92,5-(2,3-二氯苯基)-2,4-二氨基-6-氟甲基-嘧啶,C11H9Cl2FN4,和(II)227C89,甲基磺酸的甲磺酸盐5-(2,6-二氯苯基)-1-H-2,4-二氨基-6-甲基-嘧啶,C 11 H 11 Cl 2 N 4中心点CH 3 O 3 S在低温下进行。给出了两种结构的详细比较。结构(I)是非中心对称的,在空间单元P2(1)中结晶,晶胞a = 10.821(3),b = 8.290(3),c = 13.819(4)埃,β= 105.980(6)度, V = 1191.8(6)埃(3),Z = 4(每个不对称单元两个分子),密度(计算得出)= 1.600 mg / m(3)。结构(II)在棒上的三边形空间群P(1)中结晶,晶胞a = 7.686(2),b = 8.233(2),c = 12.234(2)埃,alpha = 78.379(4),beta = 87.195(4),伽玛= 86.811(4)度,V = 756.6(2)埃(3),Z = 2,密度(计算得出)= 1.603 mg / m(3)。最终的R指数[I> 2sigma(I)]为R1 = 0.0572,(I)为wR2 = 0.1003,R1 = 0.0558,(II)为wR2 = 0.0982。 R索引(所有数据)对于(I)为R1 = 0.0983,wR2 = 0.1116,对于(II),R1 = 0.1009,wR2 = 0.1117。 5-苯基-2,4-二氨基嘧啶和6-苯基-1,2,4三嗪衍生物,包括拉莫三嗪(3,5-二氨基-6-(2,3-二氯苯基)-1,2,4-三嗪),已经研究了它们对中枢神经系统的影响一段时间。这里报告的三维结构构成了一个新开发的数据库的一部分,用于对该结构系列成员及其生物学活性的详细研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号